Zhixin Medical Completes Series A Funding Round, Prepares for IPO
VAL VAID
Cardiovascular Interventional Medical Device R&D and Manufacturer
Medical Device Media Reporting Pioneer
Share Professional Medical Device Knowledge
According to information released by Tianyancha APP on March 3, VAL VAID (Shanghai) Medical Technology Co., Ltd. has completed its Series A round of financing. The amount of financing was not disclosed, and the participating investment institutions included Shanghai Sunland Investment Management Co., Ltd.
The historical financing of VAL VAID (Shanghai) Medical Technology Co., Ltd. is as follows:
VAL VAID (Shanghai) Medical Technology Co., Ltd. was established on 2021-02-02.It is a high-tech enterprise with independent innovation capabilities, focusing on the research, development, manufacturing, and sales of Class III cardiovascular interventional medical devices.Has already obtained tens of millions in angel round investment, led by a professional investment institution in China's medical industry, with a valuation reachingHundred Million.
More exciting content
Welcome to follow WeChat Video Channel
Global TOP6: China-produced Imaging Core Component Leader Launches IPO
Over 130,000 Units, Major Recall Initiated
Plummeted Over 100 Billion, "China's King of Implantable Devices" Latest Announcement
Over 15,000 Units, GE Healthcare Issues Level 1 Recall
Breaking: Major Medical Device Company May Sell Its Largest Business
Fierce Medtech: Top 15 Medical Black Technologies of 2023
This Major Move Has Been Made by United Imaging, Fosun, and Others
TOP5 Giants Double Down on China Again
"Redefining Medical Imaging," Another Breakthrough by Philips
How to Deal with Anti-Corruption and U.S. Sanctions? Mindray Medical Responds
BusinessBusiness cooperation email: qxzj@landianyiliao.com
